Global Transarterial Radioembolization (TARE) Market Research Report 2023

Report ID: 1243720 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Transarterial Radioembolization (TARE) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Microspheres
        1.2.3 Particles
        1.2.4 Drug-eluting Beads (DEBs)
        1.2.5 Radio-Embolic Microspheres
    1.3 Market by Application
        1.3.1 Global Transarterial Radioembolization (TARE) Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Uterine Fibroid Embolization
        1.3.3 Prostatic Artery Embolization
        1.3.4 Liver Tumor Embolization
        1.3.5 Trauma Embolization
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Transarterial Radioembolization (TARE) Market Perspective (2017-2028)
    2.2 Transarterial Radioembolization (TARE) Growth Trends by Region
        2.2.1 Transarterial Radioembolization (TARE) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Transarterial Radioembolization (TARE) Historic Market Size by Region (2017-2022)
        2.2.3 Transarterial Radioembolization (TARE) Forecasted Market Size by Region (2023-2028)
    2.3 Transarterial Radioembolization (TARE) Market Dynamics
        2.3.1 Transarterial Radioembolization (TARE) Industry Trends
        2.3.2 Transarterial Radioembolization (TARE) Market Drivers
        2.3.3 Transarterial Radioembolization (TARE) Market Challenges
        2.3.4 Transarterial Radioembolization (TARE) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Transarterial Radioembolization (TARE) Players by Revenue
        3.1.1 Global Top Transarterial Radioembolization (TARE) Players by Revenue (2017-2022)
        3.1.2 Global Transarterial Radioembolization (TARE) Revenue Market Share by Players (2017-2022)
    3.2 Global Transarterial Radioembolization (TARE) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Transarterial Radioembolization (TARE) Revenue
    3.4 Global Transarterial Radioembolization (TARE) Market Concentration Ratio
        3.4.1 Global Transarterial Radioembolization (TARE) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Transarterial Radioembolization (TARE) Revenue in 2021
    3.5 Transarterial Radioembolization (TARE) Key Players Head office and Area Served
    3.6 Key Players Transarterial Radioembolization (TARE) Product Solution and Service
    3.7 Date of Enter into Transarterial Radioembolization (TARE) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Transarterial Radioembolization (TARE) Breakdown Data by Type
    4.1 Global Transarterial Radioembolization (TARE) Historic Market Size by Type (2017-2022)
    4.2 Global Transarterial Radioembolization (TARE) Forecasted Market Size by Type (2023-2028)
5 Transarterial Radioembolization (TARE) Breakdown Data by Application
    5.1 Global Transarterial Radioembolization (TARE) Historic Market Size by Application (2017-2022)
    5.2 Global Transarterial Radioembolization (TARE) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Transarterial Radioembolization (TARE) Market Size (2017-2028)
    6.2 North America Transarterial Radioembolization (TARE) Market Size by Country (2017-2022)
    6.3 North America Transarterial Radioembolization (TARE) Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Transarterial Radioembolization (TARE) Market Size (2017-2028)
    7.2 Europe Transarterial Radioembolization (TARE) Market Size by Country (2017-2022)
    7.3 Europe Transarterial Radioembolization (TARE) Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Transarterial Radioembolization (TARE) Market Size (2017-2028)
    8.2 Asia-Pacific Transarterial Radioembolization (TARE) Market Size by Country (2017-2022)
    8.3 Asia-Pacific Transarterial Radioembolization (TARE) Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Transarterial Radioembolization (TARE) Market Size (2017-2028)
    9.2 Latin America Transarterial Radioembolization (TARE) Market Size by Country (2017-2022)
    9.3 Latin America Transarterial Radioembolization (TARE) Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Transarterial Radioembolization (TARE) Market Size (2017-2028)
    10.2 Middle East & Africa Transarterial Radioembolization (TARE) Market Size by Country (2017-2022)
    10.3 Middle East & Africa Transarterial Radioembolization (TARE) Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Sirtex Medical
        11.1.1 Sirtex Medical Company Detail
        11.1.2 Sirtex Medical Business Overview
        11.1.3 Sirtex Medical Transarterial Radioembolization (TARE) Introduction
        11.1.4 Sirtex Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
        11.1.5 Sirtex Medical Recent Development
    11.2 Merit Medical
        11.2.1 Merit Medical Company Detail
        11.2.2 Merit Medical Business Overview
        11.2.3 Merit Medical Transarterial Radioembolization (TARE) Introduction
        11.2.4 Merit Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
        11.2.5 Merit Medical Recent Development
    11.3 Cook Medical
        11.3.1 Cook Medical Company Detail
        11.3.2 Cook Medical Business Overview
        11.3.3 Cook Medical Transarterial Radioembolization (TARE) Introduction
        11.3.4 Cook Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
        11.3.5 Cook Medical Recent Development
    11.4 BTG Medical
        11.4.1 BTG Medical Company Detail
        11.4.2 BTG Medical Business Overview
        11.4.3 BTG Medical Transarterial Radioembolization (TARE) Introduction
        11.4.4 BTG Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
        11.4.5 BTG Medical Recent Development
    11.5 Boston Scientific Corporation
        11.5.1 Boston Scientific Corporation Company Detail
        11.5.2 Boston Scientific Corporation Business Overview
        11.5.3 Boston Scientific Corporation Transarterial Radioembolization (TARE) Introduction
        11.5.4 Boston Scientific Corporation Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
        11.5.5 Boston Scientific Corporation Recent Development
    11.6 Terumo Corporation
        11.6.1 Terumo Corporation Company Detail
        11.6.2 Terumo Corporation Business Overview
        11.6.3 Terumo Corporation Transarterial Radioembolization (TARE) Introduction
        11.6.4 Terumo Corporation Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
        11.6.5 Terumo Corporation Recent Development
    11.7 HENGRUI Medical
        11.7.1 HENGRUI Medical Company Detail
        11.7.2 HENGRUI Medical Business Overview
        11.7.3 HENGRUI Medical Transarterial Radioembolization (TARE) Introduction
        11.7.4 HENGRUI Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
        11.7.5 HENGRUI Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Transarterial Radioembolization (TARE) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Microspheres
    Table 3. Key Players of Particles
    Table 4. Key Players of Drug-eluting Beads (DEBs)
    Table 5. Key Players of Radio-Embolic Microspheres
    Table 6. Global Transarterial Radioembolization (TARE) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Transarterial Radioembolization (TARE) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Transarterial Radioembolization (TARE) Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Transarterial Radioembolization (TARE) Market Share by Region (2017-2022)
    Table 10. Global Transarterial Radioembolization (TARE) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Transarterial Radioembolization (TARE) Market Share by Region (2023-2028)
    Table 12. Transarterial Radioembolization (TARE) Market Trends
    Table 13. Transarterial Radioembolization (TARE) Market Drivers
    Table 14. Transarterial Radioembolization (TARE) Market Challenges
    Table 15. Transarterial Radioembolization (TARE) Market Restraints
    Table 16. Global Transarterial Radioembolization (TARE) Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Transarterial Radioembolization (TARE) Market Share by Players (2017-2022)
    Table 18. Global Top Transarterial Radioembolization (TARE) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transarterial Radioembolization (TARE) as of 2021)
    Table 19. Ranking of Global Top Transarterial Radioembolization (TARE) Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Transarterial Radioembolization (TARE) Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Transarterial Radioembolization (TARE) Product Solution and Service
    Table 23. Date of Enter into Transarterial Radioembolization (TARE) Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Transarterial Radioembolization (TARE) Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Transarterial Radioembolization (TARE) Revenue Market Share by Type (2017-2022)
    Table 27. Global Transarterial Radioembolization (TARE) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Transarterial Radioembolization (TARE) Revenue Market Share by Type (2023-2028)
    Table 29. Global Transarterial Radioembolization (TARE) Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Transarterial Radioembolization (TARE) Revenue Market Share by Application (2017-2022)
    Table 31. Global Transarterial Radioembolization (TARE) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Transarterial Radioembolization (TARE) Revenue Market Share by Application (2023-2028)
    Table 33. North America Transarterial Radioembolization (TARE) Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Transarterial Radioembolization (TARE) Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Transarterial Radioembolization (TARE) Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Transarterial Radioembolization (TARE) Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Transarterial Radioembolization (TARE) Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Transarterial Radioembolization (TARE) Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Transarterial Radioembolization (TARE) Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Transarterial Radioembolization (TARE) Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Transarterial Radioembolization (TARE) Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Transarterial Radioembolization (TARE) Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Sirtex Medical Company Detail
    Table 44. Sirtex Medical Business Overview
    Table 45. Sirtex Medical Transarterial Radioembolization (TARE) Product
    Table 46. Sirtex Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022) & (US$ Million)
    Table 47. Sirtex Medical Recent Development
    Table 48. Merit Medical Company Detail
    Table 49. Merit Medical Business Overview
    Table 50. Merit Medical Transarterial Radioembolization (TARE) Product
    Table 51. Merit Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022) & (US$ Million)
    Table 52. Merit Medical Recent Development
    Table 53. Cook Medical Company Detail
    Table 54. Cook Medical Business Overview
    Table 55. Cook Medical Transarterial Radioembolization (TARE) Product
    Table 56. Cook Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022) & (US$ Million)
    Table 57. Cook Medical Recent Development
    Table 58. BTG Medical Company Detail
    Table 59. BTG Medical Business Overview
    Table 60. BTG Medical Transarterial Radioembolization (TARE) Product
    Table 61. BTG Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022) & (US$ Million)
    Table 62. BTG Medical Recent Development
    Table 63. Boston Scientific Corporation Company Detail
    Table 64. Boston Scientific Corporation Business Overview
    Table 65. Boston Scientific Corporation Transarterial Radioembolization (TARE) Product
    Table 66. Boston Scientific Corporation Revenue in Transarterial Radioembolization (TARE) Business (2017-2022) & (US$ Million)
    Table 67. Boston Scientific Corporation Recent Development
    Table 68. Terumo Corporation Company Detail
    Table 69. Terumo Corporation Business Overview
    Table 70. Terumo Corporation Transarterial Radioembolization (TARE) Product
    Table 71. Terumo Corporation Revenue in Transarterial Radioembolization (TARE) Business (2017-2022) & (US$ Million)
    Table 72. Terumo Corporation Recent Development
    Table 73. HENGRUI Medical Company Detail
    Table 74. HENGRUI Medical Business Overview
    Table 75. HENGRUI Medical Transarterial Radioembolization (TARE) Product
    Table 76. HENGRUI Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022) & (US$ Million)
    Table 77. HENGRUI Medical Recent Development
    Table 78. Research Programs/Design for This Report
    Table 79. Key Data Information from Secondary Sources
    Table 80. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Transarterial Radioembolization (TARE) Market Share by Type: 2021 VS 2028
    Figure 2. Microspheres Features
    Figure 3. Particles Features
    Figure 4. Drug-eluting Beads (DEBs) Features
    Figure 5. Radio-Embolic Microspheres Features
    Figure 6. Global Transarterial Radioembolization (TARE) Market Share by Application in 2021 & 2028
    Figure 7. Uterine Fibroid Embolization Case Studies
    Figure 8. Prostatic Artery Embolization Case Studies
    Figure 9. Liver Tumor Embolization Case Studies
    Figure 10. Trauma Embolization Case Studies
    Figure 11. Others Case Studies
    Figure 12. Transarterial Radioembolization (TARE) Report Years Considered
    Figure 13. Global Transarterial Radioembolization (TARE) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Transarterial Radioembolization (TARE) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Transarterial Radioembolization (TARE) Market Share by Region: 2021 VS 2028
    Figure 16. Global Transarterial Radioembolization (TARE) Market Share by Players in 2021
    Figure 17. Global Top Transarterial Radioembolization (TARE) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transarterial Radioembolization (TARE) as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Transarterial Radioembolization (TARE) Revenue in 2021
    Figure 19. North America Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Transarterial Radioembolization (TARE) Market Share by Country (2017-2028)
    Figure 21. United States Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Transarterial Radioembolization (TARE) Market Share by Country (2017-2028)
    Figure 25. Germany Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Transarterial Radioembolization (TARE) Market Share by Region (2017-2028)
    Figure 33. China Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Transarterial Radioembolization (TARE) Market Share by Country (2017-2028)
    Figure 41. Mexico Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Transarterial Radioembolization (TARE) Market Share by Country (2017-2028)
    Figure 45. Turkey Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Transarterial Radioembolization (TARE) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Sirtex Medical Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2017-2022)
    Figure 48. Merit Medical Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2017-2022)
    Figure 49. Cook Medical Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2017-2022)
    Figure 50. BTG Medical Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2017-2022)
    Figure 51. Boston Scientific Corporation Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2017-2022)
    Figure 52. Terumo Corporation Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2017-2022)
    Figure 53. HENGRUI Medical Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
Frequently Asked Questions
Transarterial Radioembolization (TARE) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Transarterial Radioembolization (TARE) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Transarterial Radioembolization (TARE) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Mobile Substations

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More